BioSpace News Archive

S1 Biopharma, Inc. (S1) announced today that the company will participate in a panel discussion, “Innovation Across Borders: Strategies for U.S. and Chinese Companies in the Health Sciences Industry,” to be hosted by Duane Morris LLP and the Chinese Biopharmaceutical Association (USA) on Tuesday, January 8, 2019 in San Francisco, CA. The timing of the meeting coincides with the 37th Annual J.P. Morgan Healthcare Conference being held in San Francisco January 7-10, 2019.

Endologix® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today that in order to ensure optimal outcomes for patients, unrestricted sales and use of the Nellix System will cease immediately, and the product will only be available for use under clinical protocol with pre-screened patients that adhere to the current indications.

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that it has entered into a $170 million loan agreement with an affiliate of KKR, a leading global investment firm

Technavio analysts forecast the global impetigo market to grow at a CAGR of 7% during the forecast period, according to their latest market research report.

Carle Place becomes the medical cannabis leader’s fourth location in the state

Azitra, Inc. announced that Richard Andrews, President and Chief Executive Officer, is scheduled to present at Biotech Showcase™ 2019 taking place on January 7-9, 2018 at the Hilton San Francisco Union Square, San Francisco, CA

Adaptive Biotechnologies, an immune-driven medicine company, today announced that it will enter into a worldwide collaboration and license agreement with Genentech,

HealthGrowth Capital announced that George Fencl has been appointed Chief Marketing Officer, effective immediately.

Technavio analysts forecast the global live cell imaging market to grow at a CAGR of close to 9% during the forecast period, according to their latest market research report

Startup studio launches first-ever precision at-home skincare device that scans your complexion and immediately corrects hyperpigmentation leaving flawless-looking skin